ReviewTelemedicine journal and e-health : the official journal of the American Telemedicine Association2020
Telemedicine for Age-Related Macular Degeneration.
Review in Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared care.Eye (London, England) · 2026Article
- Artificial Intelligence in Ophthalmology: Acceptance, Clinical Integration, and Educational Needs in Switzerland.Journal of clinical medicine · 2025Article
- Investigation into Application of AI and Telemedicine in Rural Communities: A Systematic Literature Review.Healthcare (Basel, Switzerland) · 2025Review
- Telemedicine at a University Ophthalmology Practice During the Beginning of the COVID-19 Pandemic.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan.Clinical ophthalmology (Auckland, N.Z.) · 2023Article
- Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study.BMC ophthalmology · 2022Article
- Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic.Cureus · 2021Review
- Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.Progress in retinal and eye research · 2021Review
- A Systematic Review of Current Teleophthalmology Services in New Zealand Compared to the Four Comparable Countries of the United Kingdom, Australia, United States of America (USA) and Canada.Clinical ophthalmology (Auckland, N.Z.) · 2021Review
- Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020Review
- Hybrid Telehealth Medical Retina Clinic Due to Provider Exposure and Quarantine During COVID-19 Pandemic.Clinical ophthalmology (Auckland, N.Z.) · 2020Article
- Interest in Telehealth Among Patients With Chronic Retinal Conditions.Journal of vitreoretinal diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.